Balkrishna Industries demand revival offsets volume gains as margin pressure persists

Investment View and Valuation

Motilal Oswal Financial Services Ltd. reiterated its Neutral rating on Balkrishna Industries on July 30, 2026, despite a healthy recovery in demand and a first-quarter earnings beat. The broker sees India as the company’s principal growth driver and identifies substantial market-share potential in the Americas. However, it remains cautious about sustained margin pressure and execution risks related to the expansion into passenger car radial (PCR) and truck and bus radial (TBR) tyres.

The target price is Rs 2,259, based on 22 times FY28E EPS, compared with a CMP of Rs 2,307. MOFSL notes that valuations of 26.5 times FY27E and 22.5 times FY28E earnings are not demanding. However, it believes the future valuation multiple will depend on successful PCR/TBR market-share gains without material dilution of core margins and returns.

Q1 FY27 Financial Performance

Balkrishna Industries reported Q1 FY27 revenue of Rs 34,100 million, up 16.2 per cent year on year and above MOFSL’s estimate of Rs 30,400 million. Off-highway tyre volumes increased 16.2 per cent year on year and 9 per cent sequentially to a record 93,770 tonnes, ahead of the broker’s estimate of 87,117 tonnes. Blended realisations rose 6.3 per cent year on year to about Rs 364,000 per tonne, broadly in line with estimates.

EBITDA was broadly in line with MOFSL’s forecast, but the EBITDA margin declined to 20.6 per cent, below the 22 per cent estimate. The decline reflected an unfavourable regional mix, higher commodity input and freight costs, greater promotional expenditure and a higher share of lower-margin domestic sales.

Adjusted PAT exceeded estimates primarily because of a Rs 570 million mark-to-market gain and higher other income. The board also declared an interim dividend of Rs 4 per share.

Market Demand and Regional Growth

Management reported stable conditions in Europe, supported by a favourable agricultural season and a low base. Europe market share is about 7–8 per cent, dealer inventories are normal and there is no indication of channel stocking.

India accounted for about 40 per cent of off-highway tyre volume and delivered broad-based growth across agriculture, mining, industrial and construction applications. Growth was supported by replacement demand, market-share gains and infrastructure activity. Management estimates market shares of about 18–19 per cent in India, 7–8 per cent in Europe and 3–4 per cent in the US.

The Americas are improving, led by the US after tariff rates stabilised at 10 per cent. Management expects growth to be supported by premium positioning, sharper go-to-market execution and room for further penetration.

Pricing, Cost Pressures and Capital Expenditure

Management implemented cumulative price increases of about 5 per cent across markets in Q1 FY27, with the full benefit expected from Q2 FY27. It nevertheless expects raw-material inflation to continue through Q2 FY27 and partly into Q3 FY27.

A projected roughly 5 per cent increase in raw-material costs could have about a 3 per cent effect on sales realisation and leave about 2 per cent near-term margin pressure if present conditions persist. Freight remains elevated amid geopolitical uncertainty. Management is balancing volume growth and margin discipline, using expanded carbon-black capacity to improve manufacturing efficiency and scaling the on-highway business.

About Rs 1,000 crore of capex was incurred in Q1 FY27, with a further Rs 1,500–2,000 crore planned over the remaining nine months of FY27. Growth capex is expected to taper materially from FY28.

PCR and TBR Expansion

Balkrishna Industries began TBR tyre supplies in April 2026 and introduced selected two-wheeler products for the domestic market. PCR tyre launches remain on schedule. Management aims to increase revenue 2.2 times over five years to Rs 23,000 crore.

MOFSL estimates a 13 per cent volume CAGR during FY26–28E, but believes building meaningful PCR and TBR positions in India could take longer because incumbents possess established brands. It also expects carbon black and PCR/TBR to be lower-margin than the core business, potentially diluting margins and returns as their contribution rises.

MOFSL Estimates and Key Risks

MOFSL raised its FY27E and FY28E sales estimates by 8.7 per cent and 9.7 per cent, respectively, and increased adjusted PAT estimates by 9.7 per cent and 4.8 per cent. However, it reduced EBITDA-margin estimates by 70 basis points for FY27E and 120 basis points for FY28E.

• Sustained raw-material inflation and elevated freight costs could keep margins under pressure.
• Unfavourable regional and product mix, promotional expenditure and a higher share of lower-margin domestic sales remain margin risks.
• PCR and TBR expansion could take longer because of established incumbent brands in India.
• The lower-margin nature of carbon black and PCR/TBR could dilute margins and returns as these businesses scale.
• The valuation outlook depends on gaining PCR/TBR market share without materially diluting the margins and returns of the core business.